Back to Legal Insights & Articles
Corporate Advisory
Lisha SharmaAugust 02, 20268 min read
Akros Legal Publication

Executive Summary

Corporate restructuring and statutory mergers carry complex liability exposures for executive and non-executive directors. This article details risk mitigation protocols under the Companies Act, 2013, Indemnity deeds, and D&O insurance coverage.

1. The Evolving Framework under Companies Act, 2013

Section 166 of the Companies Act, 2013 codifies fiduciary duties of directors, requiring them to act in good faith, exercise due care, and avoid conflicts of interest. In cross-border M&A and corporate schemes of arrangement, non-compliance by target entities can trigger personal liability for board members.

Section 149(12) affords immunity to independent and non-executive directors only if non-compliance occurred without their knowledge, consent, or connivance, or where they acted with due diligence.

2. Contractual Protections: Indemnities & Escrow Shields

To insulate directors against legacy liabilities of target entities, corporate transactions must incorporate robust Representation & Warranty (R&W) insurance, specific tax indemnity covenants, and escrow retention mechanisms.

3. Key Recommendations for Board Governance

Boards should institute mandatory independent legal due diligence reports, ensure clear recording of dissenting notes in board minutes, and review D&O insurance tail coverage prior to executing definitive agreements.

Key Practice Takeaways

Ensure detailed recording of board deliberations and dissenting opinions in official minutes.
Structure specific tax and environmental indemnities in transaction agreements.
Secure D&O Tail Insurance covering legacy liabilities for at least 6 years post-merger.
Direct Legal Consultation

Need tailored advice or legal representation on issues discussed in this commentary? Connect directly with our senior partners and advocates.